CELLOMICS INC
S-1/A, EX-27, 2000-11-16
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CELLOMICS INC, S-1/A, EX-24.1, 2000-11-16
Next: CELLOMICS INC, S-1/A, EX-27.1, 2000-11-16



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from our
unaudited interim financial statements as of and for the nine months ended
September 30, 2000 and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      23,034,134
<SECURITIES>                                         0
<RECEIVABLES>                                3,137,446
<ALLOWANCES>                                         0
<INVENTORY>                                    594,419
<CURRENT-ASSETS>                            28,287,142
<PP&E>                                       5,017,127
<DEPRECIATION>                             (1,252,524)
<TOTAL-ASSETS>                              32,051,745
<CURRENT-LIABILITIES>                        8,892,293
<BONDS>                                              0
                       41,521,247
                                          0
<COMMON>                                        42,700
<OTHER-SE>                                (19,760,958)
<TOTAL-LIABILITY-AND-EQUITY>                32,051,745
<SALES>                                      5,390,006
<TOTAL-REVENUES>                             6,796,355
<CGS>                                        2,190,050
<TOTAL-COSTS>                               17,774,558
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,064,301
<INCOME-PRETAX>                           (12,891,489)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (12,891,489)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (12,891,489)
<EPS-BASIC>                                    (10.96)
<EPS-DILUTED>                                  (10.96)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission